Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Arcus Biosciences, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 187
- +8 vs. Q2 2023
- Shares held
- 52.8M
- −1.23M (−2.3%) vs. Q2 2023
- Total value
- $947.9M
- −$148.6M (−13.6%) vs. Q2 2023
- New holders
- 31
- 53 more added
- Sold out
- 23
- 73 more reduced
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RCUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 231 | $3.78B |
| Q1 2026 | 211 | $2.57B |
| Q4 2025 | 209 | $2.89B |
| Q3 2025 | 190 | $1.37B |
| Q2 2025 | 186 | $811.5M |
| Q1 2025 | 187 | $763.3M |
| Q4 2024 | 186 | $1.25B |
| Q3 2024 | 187 | $815.7M |
| Q2 2024 | 193 | $790.9M |
| Q1 2024 | 172 | $997.7M |
| Q4 2023 | 185 | $1.01B |
| Q3 2023 | 187 | $947.9M |
| Q2 2023 | 181 | $1.11B |
| Q1 2023 | 180 | $1.01B |
| Q4 2022 | 200 | $1.11B |
| Q3 2022 | 183 | $1.37B |
| Q2 2022 | 173 | $1.33B |
| Q1 2022 | 157 | $1.60B |
| Q4 2021 | 142 | $2.06B |
| Q3 2021 | 131 | $1.68B |
| Q2 2021 | 130 | $1.24B |
| Q1 2021 | 148 | $1.25B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Arcus Biosciences, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −9,995−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Robeco Institutional Asset Management B.V. | 0 | $0 | 0.00% | −1,143−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −130−100.0% | Sold out |
| Tucker Asset Management LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| FinTrust Capital Advisors, LLC | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Disciplined Investments, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |
| Tekla Capital Management LLC | – | – | – | – | Not filed |